Drug costs – medicarereport.org

Sunday, December 10, 2023

Latest:

Health Care Finance Part D/Prescription Drugs

Eileen Cook December 6, 2023December 6, 2023 Drug costs, Drug price Transparency, Medicare Part D

The Mark Cuban effect on drug pricing

(By Paige Twenter for Becker’s Hospital Review) In January 2022, entrepreneur and “Shark Tank” star Mark Cuban launched an online

FDA Health Care Finance National Institutes of Health Part D/Prescription Drugs

Eileen Cook November 17, 2023 Drug Companies, Drug costs, Drug Research, Healthcare Costs, Medicare Part D, National Institutes of Health

Sen. Sanders pushes NIH to rein in drug prices

(By Sydney Lupkin for NPR) Can the National Institutes of Health bring down drug prices? It doesn’t approve new medicines

Health Care Finance Health Care Redesign Health Insurance Part D/Prescription Drugs

Eileen Cook September 1, 2023September 5, 2023 Drug costs, GoodRx

GoodRx launches patient insurance check tool for providers

(By Jakob Emerson for Becker’s Hospital Review) GoodRx has launched a new feature that allows providers to check a patient’s

CDC Health Care Finance Part D/Prescription Drugs Uninsured/Underinsured Women's Health

Eileen Cook June 5, 2023June 5, 2023 0 Comments CDC, CMS, Drug costs, Skipping doses, Uninsured, Women

CDC: Drug costs keep millions from taking medications as prescribed

(By Erica Carbajal for Becker’s Hospital Review) Newly released data from the CDC shows more than 9 million U.S. adults

FTC Legal Actions/Court Decisions Part D/Prescription Drugs

Eileen Cook May 22, 2023May 22, 2023 0 Comments Drug Companies, Drug costs, FTC, Legal Actions, PBM Industry

A More Aggressive FTC Is Starting to Target Drug Mergers and Industry Middlemen

(By Arthur Allen for KFF Health News) Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal